Literature DB >> 26577922

The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.

Stéphanie Herkenne1, Cécile Paques2, Olivier Nivelles2, Michelle Lion2, Khalid Bajou3, Thomas Pollenus2, Marie Fontaine2, Peter Carmeliet4, Joseph A Martial2, Ngoc-Quynh-Nhu Nguyen2, Ingrid Struman5.   

Abstract

In endothelial cells, binding of vascular endothelial growth factor (VEGF) to the receptor VEGFR2 activates multiple signaling pathways that trigger processes such as proliferation, survival, and migration that are necessary for angiogenesis. VEGF-bound VEGFR2 becomes internalized, which is a key step in the proangiogenic signal. We showed that the urokinase plasminogen activator receptor (uPAR) interacted with VEGFR2 and described the mechanism by which this interaction mediated VEGF signaling and promoted angiogenesis. Knockdown of uPAR in human umbilical vein endothelial cells (HUVECs) impaired VEGFR2 signaling, and uPAR deficiency in mice prevented VEGF-induced angiogenesis. Upon exposure of HUVECs to VEGF, uPAR recruited the low-density lipoprotein receptor-related protein 1 (LRP-1) to VEGFR2, which induced VEGFR2 internalization. Thus, the uPAR-VEGFR2 interaction is crucial for VEGF signaling in endothelial cells.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26577922     DOI: 10.1126/scisignal.aaa2403

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  18 in total

1.  SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.

Authors:  Hyeong Sim Choi; Min Kyoung Kim; Kangwook Lee; Kang Min Lee; Youn Kyung Choi; Yong Cheol Shin; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Oncotarget       Date:  2016-05-31

2.  Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.

Authors:  Shuang He; Tiechan Zhao; Hao Guo; Yanzhi Meng; Gangjian Qin; David A Goukassian; Jihong Han; Xuimei Gao; Yan Zhu
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 3.  Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis.

Authors:  Hua Mao; Liang Xie; Xinchun Pi
Journal:  Front Cardiovasc Med       Date:  2017-05-22

4.  P311 Deficiency Leads to Attenuated Angiogenesis in Cutaneous Wound Healing.

Authors:  Song Wang; Xiaorong Zhang; Wei Qian; Daijun Zhou; Xunzhou Yu; Rixing Zhan; Ying Wang; Jun Wu; Weifeng He; Gaoxing Luo
Journal:  Front Physiol       Date:  2017-12-06       Impact factor: 4.566

Review 5.  COVID-19 and pneumonia: a role for the uPA/uPAR system.

Authors:  Daniele D'Alonzo; Maria De Fenza; Vincenzo Pavone
Journal:  Drug Discov Today       Date:  2020-06-18       Impact factor: 7.851

Review 6.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

7.  Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.

Authors:  Miho Kobayashi; Ikumi Wakabayashi; Yasuhiro Suzuki; Kashio Fujiwara; Masanori Nakayama; Tetsuro Watabe; Yasufumi Sato
Journal:  Angiogenesis       Date:  2020-10-14       Impact factor: 10.658

8.  The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

Authors:  Mirko Manetti; Serena Guiducci; Marco Matucci-Cerinic
Journal:  Arthritis Res Ther       Date:  2016-02-05       Impact factor: 5.156

9.  Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity.

Authors:  Zhengping Hu; Issahy Cano; Kahira L Saez-Torres; Michelle E LeBlanc; Magali Saint-Geniez; Yin-Shan Ng; Pablo Argüeso; Patricia A D'Amore
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

10.  CD73+ extracellular vesicles inhibit angiogenesis through adenosine A2B receptor signalling.

Authors:  Roberta Angioni; Cristina Liboni; Stephanie Herkenne; Ricardo Sánchez-Rodríguez; Giulia Borile; Elisabetta Marcuzzi; Bianca Calì; Maurizio Muraca; Antonella Viola
Journal:  J Extracell Vesicles       Date:  2020-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.